methotrexate has been researched along with Esthesioneuroblastoma, Olfactory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jekunen, AP; Kairemo, KJ; Kajanti, MJ; Lehtonen, HP | 1 |
| Buckner, JC; Lewis, JE; McElroy, EA | 1 |
2 review(s) available for methotrexate and Esthesioneuroblastoma, Olfactory
| Article | Year |
|---|---|
Treatment of olfactory neuroblastoma. A report of 11 cases.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Esthesioneuroblastoma, Olfactory; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Nasal Cavity; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Nose Neoplasms; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Survival Rate | 1996 |
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Mesna; Methotrexate; Middle Aged; Mitomycin; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1998 |